A new study published in the Journal of Vascular Access found that subcutaneous anchors are more effective than adhesive securement devices in preventing catheter dislodgement. The study showed a significant reduction in unplanned catheter replacements and complications, with SecurAcath demonstrating a 99% success rate.
Current sequencing methods miss gene fusions in many non-small cell lung cancer patients, denying them access to targeted therapies. Novel genomic technology ASPYRE provides ultra-sensitive detection of gene fusions from RNA.
A new study demonstrates that standardizing ultrasound-guided PIV insertions using an innovative sterile barrier dressing, UltraDrape, improves outcomes and reduces costs. The results show a 73% reduction in supply costs and a 50% decrease in staff time for insertions.
Researchers found that subcutaneous anchor securement systems significantly reduced catheter migration (1.76%) compared to other methods (4.17%, 6.77%, and 9.69%). The study adds to the evidence supporting the use of SecurAcath, which has been shown to reduce bloodstream infections and prolong catheter lifespan.
The Infusion Nurses Society has adopted the international Aseptic Non Touch Technique (ANTT) framework as a standard in its 2021 Infusion Therapy Standards of Practice. ANTT reduces variability and improves patient safety, particularly with ultrasound-guided peripheral IV insertions.
The 2021 INF Standards of Practice expanded its guidance on needleless connectors to include anti-reflux technology, which causes the least amount of blood reflux. Anti-reflux needleless connectors can prevent catheter occlusions, failure, and infections by automatically eliminating unintentional blood reflux.
A randomized clinical trial demonstrated the reliability of using circulating tumor cell count to guide frontline therapy choice for patients with estrogen receptor-positive (ER+) HER2-negative (HER2) metastatic breast cancer. The CTC count significantly improved progression-free survival for patients with high CTC counts, while hormon...
The minimally invasive Ellipsys system uses a small needle puncture to create a permanent vascular access for dialysis patients, resulting in improved patency rates and high levels of patient satisfaction. The system has been shown to outperform surgically created fistulas, with a reported 96% one-year patency rate.
A new survey among vascular access and emergency department clinicians reveals clinically meaningful differences in ultrasound-guided peripheral IV (UGPIV) procedures and supplies. The study highlights the urgent need for standardized and consistent UGPIV practices to minimize contamination and promote patient safety.
The new study found that both Ellipsys and WavelinQ systems enabled patients to start dialysis sooner compared to surgery, offering significant quality-of-life benefits. The Ellipsys System demonstrated higher technical success rate and more durable access, with 82% of Ellipsys fistulas still functional at 12 months.
A new study shows that the Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures. The technology uses a small needle puncture and catheter to create an endovascular AVF, reducing the average time from fistula creation to ...
A new study published in the Journal of Vascular Surgery found that the Ellipsys System created durable vascular access for ESRD patients who require hemodialysis, with a patency rate of 96% after one year. This minimally invasive procedure reduces reliance on riskier vascular access options and improves patient safety.
Researchers at SKI Vascular Center in Arizona have pioneered a minimally invasive procedure, Ellipsys, which provides easier access to a patient's bloodstream for dialysis treatments. The new technology shows promise in reducing complications and improving quality of life for patients with kidney failure.
Researchers found that nearly 92 percent of Ellipsys fistulas were still functional after two years, with patients reporting high levels of satisfaction. The study's results confirm the Ellipsys system provides good vascular access while reducing pain and discomfort associated with traditional fistula surgery.
A new study reports high patient satisfaction with a minimally invasive approach to creating vascular access for kidney patients requiring hemodialysis. The Ellipsys Vascular Access System showed nearly all dialysis access sites remained functional after two years, significantly improving upon surgically created fistulas.